Identification of Streptococcus pyogenes M1_UK clone in Canada

Affiliations

¹ Public Health Agency of Canada, National Microbiology Laboratory, Winnipeg, MB R3E 3R2, Canada.
² Public Health Agency of Canada, National Microbiology Laboratory, Winnipeg, MB R3E 3R2, Canada. Electronic address: irene.martin@canada.ca.
³ Centre for Immunization and Respiratory Infectious Diseases, Ottawa, ON, Canada.

Comment

Walter Demczuk et al. Lancet Infect Dis. 2019 Dec.

. 2019 Dec;19(12):1284-1285.

doi: 10.1016/S1473-3099(19)30622-X.

¹ Public Health Agency of Canada, National Microbiology Laboratory, Winnipeg, MB R3E 3R2, Canada.
² Public Health Agency of Canada, National Microbiology Laboratory, Winnipeg, MB R3E 3R2, Canada. Electronic address: irene.martin@canada.ca.
³ Centre for Immunization and Respiratory Infectious Diseases, Ottawa, ON, Canada.

No abstract available

Comment on

Emergence of dominant toxigenic M1T1 Streptococcus pyogenes clone during increased scarlet fever activity in England: a population-based molecular epidemiological study.
Lynskey NN, Jauneikaite E, Li HK, Zhi X, Turner CE, Mosavie M, Pearson M, Asai M, Lobkowicz L, Chow JY, Parkhill J, Lamagni T, Chalker VJ, Sriskandan S. Lynskey NN, et al. Lancet Infect Dis. 2019 Nov;19(11):1209-1218. doi: 10.1016/S1473-3099(19)30446-3. Epub 2019 Sep 10. Lancet Infect Dis. 2019. PMID: 31519541 Free PMC article.